News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,970 Results
Type
Article (8015)
Company Profile (139)
Press Release (474816)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166740)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238195)
Policy (17899)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (479)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33157)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10329)
Artificial intelligence (308)
ASCO (159)
Autoimmune disease (195)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3550)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (168)
Celiac Disease (1)
Cell therapy (466)
Cervical cancer (34)
Clinical research (47722)
Collaboration (1200)
Compensation (1386)
Complete response letters (33)
COVID-19 (749)
CRISPR (62)
C-suite (702)
Cystic fibrosis (84)
Data (5489)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (333)
Diagnostics (4141)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (158)
Earnings (73002)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87424)
Executive appointments (679)
FDA (12268)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (889)
Gene editing (123)
Generative AI (9)
Gene therapy (309)
GLP-1 (284)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9306)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (934)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (246)
Interviews (41)
IPO (12377)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (488)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (510)
Marketing (6)
MASH (115)
Medical device (8629)
Medtech (8747)
Mergers & acquisitions (14347)
Metabolic disorders (686)
mRNA (50)
Multiple sclerosis (101)
NASH (4)
Neurodegenerative disease (211)
Neuropsychiatric disorders (38)
Neuroscience (1778)
NextGen: Class of 2026 (3150)
Non-profit (842)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (168)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (455)
Patient recruitment (474)
Peanut (31)
People (41108)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15425)
Phase 2 (21311)
Phase 3 (14348)
Pipeline (6616)
Policy (18)
Postmarket research (1570)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (555)
Real estate (3019)
Recruiting (6)
Regulatory (14660)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (148)
Series B (116)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (310)
Venture capital (17)
Weight loss (69)
Women's health (74)
Date
Today (58)
Last 7 days (259)
Last 30 days (1117)
Last 365 days (19124)
2026 (10604)
2025 (19251)
2024 (22985)
2023 (26538)
2022 (34587)
2021 (37178)
2020 (33468)
2019 (23257)
2018 (17469)
2017 (18767)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17831)
Australia (2090)
California (11477)
Canada (3040)
China (501)
Colorado (463)
Connecticut (388)
Delaware (202)
Europe (24559)
Florida (1710)
Georgia (364)
Hawaii (2)
Idaho (46)
Illinois (674)
India (41)
Indiana (308)
Iowa (13)
Japan (384)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1149)
Massachusetts (7561)
Michigan (299)
Minnesota (535)
Mississippi (4)
Missouri (77)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2527)
New Mexico (12)
New York (2728)
North Carolina (1223)
North Dakota (4)
Northern California (5705)
Ohio (265)
Oklahoma (14)
Oregon (14)
Pennsylvania (2187)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4765)
Tennessee (113)
Texas (1848)
United States (37354)
Utah (343)
Vermont (1)
Virginia (144)
Washington D.C. (38)
Washington State (891)
West Virginia (1)
Wisconsin (72)
482,970 Results for "blackfynn inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Stephen Hahn, M.D., recent FDA Commissioner, joins Blackfynn Board of Directors
Blackfynn, a company using a systematic approach that combines data, technology and disease-specific clinical expertise to develop a growing pipeline of targeted, clinical-stage therapeutics for Parkinson’s and neurodegeneration, announced that Stephen Hahn, M.D. will join its Board of Directors.
February 23, 2021
·
3 min read
Drug Development
Blackfynn Builds Therapeutic Pipeline with Option to a Phase 3-Ready Drug for Parkinson’s
Blackfynn, a company using a systematic approach that combines data, technology and disease-specific clinical expertise to develop a growing pipeline of targeted, clinical-stage therapeutics for Parkinson’s and neurodegeneration, today announced that it has entered into an agreement with an undisclosed partner to acquire rights to a Phase 3-ready drug to treat Parkinson’s.
February 18, 2021
·
4 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Press Releases
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
July 16, 2026
·
3 min read
Press Releases
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
·
17 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders’ Equity Requirement
July 20, 2026
·
4 min read
1 of 48,297
Next
